A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia (VAYHIT1)

Bennett, Ashwini (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

HREC Reference Number: HREC/90763/Alfred-2022
SSA Reference Number: SSA/90763/MonH-2023-367225(v1)
ERM Number: 90763
Monash Health Local Reference: RES-23-0000-273X

Status	Active
Effective start/end date	15/06/23 → 14/06/28

A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia (VAYHIT1)

Project Details

Project Description